Literature DB >> 10199783

Prolonged exposure of human beta-cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine.

K Hostens1, Z Ling, C Van Schravendijk, D Pipeleers.   

Abstract

The disproportionate hyperproinsulinemia in type 2 diabetes has been attributed to either a primary beta-cell defect or a secondary dysregulation of beta cells under sustained hyperglycemia. This study examines the effect of a 10- to 13-day exposure to 20 mmol/L glucose on subsequent proinsulin and insulin release by human islets isolated from nondiabetic donors. Compared to control preparations kept at 6 mmol/L glucose, the high glucose cultured beta-cells released more proinsulin and less insulin during perifusion at 5, 10, or 20 mmol/L glucose. The lower amounts of secreted insulin resulted from a marked reduction in cellular insulin content (5-fold lower than in controls). The higher amount of secreted proinsulin is attributed to the sustained state of cellular activation that is known to occur after prolonged exposure to high glucose levels. This activated state of the beta-cell population is also held responsible for its higher secretory responsiveness to 5 mmol/L arginine at a submaximal (5 mmol/L) glucose concentration (8-fold higher proinsulin levels than in the control population). It results, together with the reduction in cellular insulin content, in 7- to 10-fold higher proinsulin over insulin ratios in the medium; at 5 mmol/L glucose, this extracellular ratio is similar to that in the cells. These data add direct support to the view that a disproportionate hyperproinsulinemia can result from a sustained activation of human beta-cells after prolonged exposure to elevated glucose levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199783     DOI: 10.1210/jcem.84.4.5621

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes.

Authors:  I Truyen; P De Pauw; P N Jørgensen; C Van Schravendijk; O Ubani; K Decochez; E Vandemeulebroucke; I Weets; R Mao; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2005-10-07       Impact factor: 10.122

2.  Elevated Intact Proinsulin Levels During an Oral Glucose Challenge Indicate Progressive ß-Cell Dysfunction and May Be Predictive for Development of Type 2 Diabetes.

Authors:  Andreas Pfützner; Iris Hermanns; Sanja Ramljak; Filiz Demircik; Anke H Pfützner; Peter H Kann; Matthias M Weber
Journal:  J Diabetes Sci Technol       Date:  2015-09-29

Review 3.  Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

Authors:  Michael R Rickels; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 4.  Recovery of endocrine function after islet and pancreas transplantation.

Authors:  Michael R Rickels
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

5.  Effects of GLP-1 and GIP on Islet Function in Glucose-Intolerant, Pancreatic-Insufficient Cystic Fibrosis.

Authors:  Sarah C Nyirjesy; Amy J Peleckis; Jack N Eiel; Kathryn Gallagher; Andriana Doliba; Abigail Tami; Anneliese J Flatt; Diva D De Leon; Denis Hadjiliadis; Saba Sheikh; Darko Stefanovski; Robert Gallop; David A D'Alessio; Ronald C Rubenstein; Andrea Kelly; Michael R Rickels
Journal:  Diabetes       Date:  2022-10-01       Impact factor: 9.337

6.  Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.

Authors:  Michael R Rickels; Rebecca Mueller; James F Markmann; Ali Naji
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

7.  {beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants.

Authors:  Michael R Rickels; Rebecca Mueller; Karen L Teff; Ali Naji
Journal:  J Clin Endocrinol Metab       Date:  2010-01-22       Impact factor: 5.958

8.  High residual C-peptide likely contributes to glycemic control in type 1 diabetes.

Authors:  Michael R Rickels; Carmella Evans-Molina; Henry T Bahnson; Alyssa Ylescupidez; Kristen J Nadeau; Wei Hao; Mark A Clements; Jennifer L Sherr; Richard E Pratley; Tamara S Hannon; Viral N Shah; Kellee M Miller; Carla J Greenbaum
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

9.  Beta Cell Stress in Insulin Independent Subjects Following Total Pancreatectomy and Autologous Islet Transplantation.

Authors:  Khawla F Ali; Vicente T San Martin; Betül Hatipoğlu
Journal:  Turk Klin Immunol Alerji       Date:  2019-04-12

10.  Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls.

Authors:  Jean-Claude Henquin; Majeed M Ibrahim; Jacques Rahier
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.